ClinVar Miner

Submissions for variant NM_000286.3(PEX12):c.961_964del (p.Gly321fs) (rs749650201)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000674917 SCV000800332 likely pathogenic Peroxisome biogenesis disorder type 3B; Peroxisome biogenesis disorder 3A 2018-06-04 criteria provided, single submitter clinical testing
Invitae RCV001382391 SCV001581142 pathogenic Peroxisome biogenesis disorder 3A 2020-08-11 criteria provided, single submitter clinical testing This sequence change results in a premature translational stop signal in the PEX12 gene (p.Gly321Metfs*12). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 39 amino acids of the PEX12 protein. This variant is present in population databases (rs749650201, ExAC 0.02%). This variant has not been reported in the literature in individuals with PEX12-related conditions. ClinVar contains an entry for this variant (Variation ID: 558619). This variant disrupts the C-terminus of the PEX12 protein. Other variant(s) that disrupt this region (p.Gln337*) have been determined to be pathogenic (Invitae). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.